🇺🇸 FDA
Patent

US 7101547

Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies

granted A61KA61K2039/505

Quick answer

US patent 7101547 (Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505